Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 1 de 1
Filter
Add more filters











Database
Language
Publication year range
1.
Ren Fail ; 46(2): 2379008, 2024 Dec.
Article in English | MEDLINE | ID: mdl-39034431

ABSTRACT

Despite efforts to find effective drugs for sepsis-associated acute kidney injury (SA-AKI), mortality rates in patients with SA-AKI have not decreased. Our study evaluated the protective effects of isoflavone osajin (OSJ) on SA-AKI in rats by targeting inflammation, oxidative stress, and apoptosis, which represent the cornerstones in the pathophysiological mechanism of SA-AKI. Polymicrobial sepsis was induced in rats via the cecal ligation and puncture (CLP) technique. Markers of oxidative stress were evaluated in kidney tissues using biochemical methods. The expression of interleukin-33 (IL-33), 8-hydroxydeoxyguanosine (8-OHdG), caspase-3, and kidney injury molecule-1 (KIM-1) was evaluated as indicators of inflammation, DNA damage, apoptosis, and SA-AKI respectively in the kidney tissues using immunohistochemical and immunofluorescent detection methods. The CLP technique significantly (p < 0.001) increased lipid peroxidation (LPO) levels and significantly (p < 0.001) decreased the activities of superoxide dismutase and catalase in kidney tissues. In the renal tissues, strong expression of IL-33, 8-OHdG, caspase-3, and KIM-1 was observed with severe degeneration and necrosis in the tubular epithelium and intense interstitial nephritis. In contrast, the administration of OSJ significantly (p < 0.001) reduced the level of LPO, markedly improved biomarkers of antioxidant status, decreased the levels of serum creatinine and urea, lowered the expression of IL-33, 8-OHdG, caspase-3, and KIM-1 and alleviated changes in renal histopathology. A promising binding score was found via a molecular docking investigation of the OSJ-binding mode with mouse IL-33 (PDB Code: 5VI4). Therefore, OSJ protects against SA-AKI by suppressing the IL-33/LPO/8-OHdG/caspase-3 pathway and improving the antioxidant system.


Subject(s)
Acute Kidney Injury , Antioxidants , Apoptosis , Kidney , Molecular Docking Simulation , Oxidative Stress , Sepsis , Animals , Acute Kidney Injury/metabolism , Acute Kidney Injury/etiology , Acute Kidney Injury/drug therapy , Acute Kidney Injury/prevention & control , Antioxidants/pharmacology , Antioxidants/therapeutic use , Sepsis/complications , Sepsis/drug therapy , Rats , Oxidative Stress/drug effects , Male , Apoptosis/drug effects , Kidney/pathology , Anti-Inflammatory Agents/pharmacology , Anti-Inflammatory Agents/therapeutic use , Isoflavones/pharmacology , Isoflavones/therapeutic use , Disease Models, Animal , Interleukin-33/metabolism , Lipid Peroxidation/drug effects , Caspase 3/metabolism , Rats, Sprague-Dawley , Cell Adhesion Molecules
SELECTION OF CITATIONS
SEARCH DETAIL